Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis
Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Please explain how Qixleef will be anything soon ? NOTHING !
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(58)
•••
Post by SamV21on May 20, 2022 4:26pm
137 Views
Post# 34699462

Please explain how Qixleef will be anything soon ? NOTHING !

Please explain how Qixleef will be anything soon ? NOTHING !Not finished Phase 2 anywhere, and no one knows when that might or if happen, Guy has stopped studies before, plus it will take another 500,000,000 to bring Qixleef to a saleable product.
You are pure exaggeration about reality, that is basic fraud , so get your facts straight ! .Qixleef needs phase 3, 4 and final review before it can get a DIN and be sold  ANYWHERE ! , Tetra does not have the funds to complete or have Qixleef approved and it is worth nothing at this point , JUST A DREAM.Tetra does not have the funds to launch Reduvo , the deal is 50% due and payable on Health Canada approval ........ !Typical you come on here and make it sound like anything will happen anytime soon . Go scam and exaggerate the facts somewhere else and find some new people to make false progress reports to.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities